2023 MSK Pulmo-Oncology Symposium - On Demand

Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement, infections, and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

This state-of-the-art, case-based, multidisciplinary on demand curriculum addresses selected topics relevant to the respiratory health of patients with cancer. In this first time offering, clinical experts from Memorial Sloan Kettering (MSK) and other institutions present an up-to-date overview of cutting-edge cancer therapies and best practice strategies in the evaluation and management of lung disease. 

Who Would Benefit from this On Demand

This program is designed for healthcare professionals in pulmonology, hematology and oncology, and other disciplines interested in the intersection of pulmonology and oncology.

On Demand Content & Access

This on demand includes 13 recorded lectures and a case-based panel discussion from the live Symposium held on June 9, 2023 as well as PDF's of the speakers' presentations. Lectures from expert faculty of various disciplines include:

• Role of Pulmonologist in Diagnosis and Management of Lung Cancer (Keynote Presentation)
• Targeted and Immunologic Therapies for Lung Cancer
• Immune Checkpoint Inhibitor Pneumonitis: A Pulmonologist’s Perspective
• Rechallenging Immune Checkpoint Inhibition After irAEs: Brave or Unwise?
• Management of Refractory Immune Checkpoint Inhibitor Pneumonitis: A Rheumatologist’s Perspective
• Keep it Cool: Bronchoscopic CryoCore Biopsies in the Oncologic Patient Population
• Management of Malignant Pleural Effusions
• Interstitial Lung Abnormality (Keynote Presentation) 
• Idiopathic Pulmonary Fibrosis and Lung Cancer Surgery
• Idiopathic Pulmonary Fibrosis and Non-Surgical Lung Cancer Therapies
• Pulmonary Graft vs Host Disease: Management, Limitations and Future Directions
• Respiratory Infections In Transplant Cellular Therapy Recipients in The Era of Molecular Diagnostics
• Intractable Cough in Cancer Patients
  

View the brochure from the Live Symposium for additional details.

To purchase this on demand program, select the 'Register' tab at the top of this page. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

This on demand program will be available for purchase until December 31, 2023.
Access to the videos and claiming credit will be available until March 1, 2024.

1. Explain the role of pulmonologist in diagnosis and management of lung cancer
2. Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
3. Implement strategies for diagnosis and management of infectious and non infectious complications of stem cell transplant
4. Implement approaches to symptom management of cough and malignant pleural effusion related dyspnea
5. Explain clinical significance of interstitial lung abnormalities and pulmonary fibrosis in lung cancer management

On Demand Fees

• Physicians (MDs, PhDs, PharmDs, and DOs): $150
• Advanced Practice Providers: $100
• Nurses, Residents, Fellows, and Other Healthcare Providers: $75
• MSK Employees: Complimentary

A discount is available for MSK Alumni and MSK Cancer Alliance members to register for this on demand program. If you are a member of one of these groups, contact [email protected] for details and a promotion code. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This MSK CME on demand program is non-refundable

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: June 9, 2023; Original Release Date: June 26, 2023; Termination Date: March 1, 2024

MSK Symposium Directors

Alexander I. Geyer, MD
Assistant Attending, Clinical Director
Assistant Professor of Clinical Medicine 
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Leontine L.J. van Elden, MD, PhD
Associate Attending
Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Christina M. Hess, MS, MSN
Nurse Practitioner, Pulmonary Service
Memorial Sloan Kettering Cancer Center

MSK Planning Committee

Mohit Chawla, MD, FCCP
Chief, Pulmonary Service
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Louise M. Cunningham, SLPD, CCC-SLP, BCS-S
Speech-Language Pathologist
Manager Speech and Swallowing
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Leslie E. Kao, MD, MS
Fellow, Pulmonary and Critical Care Medicine Fellowship
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Invited Faculty 

Karmela Kim Chan, MD
Assistant Attending Physician, Assistant Professor of Medicine
Associate Program Director, Adult Rheumatology Fellowship Program
Hospital for Special Surgery
Weill Cornell Medical Center-New York Presbyterian
New York, NY 

Charles A. Powell, MD, MBA
Professor of Medicine
System Division Chief for Pulmonary, Critical Care and Sleep Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Suhail Raoof, MD
Professor of Medicine and Radiology
Director, Lung Institute
Phyllis and William Mack Chair of Pulmonary Medicine
Northwell Health
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, NY

Willemijn Theelen, MD, PhD
Pulmonologist
Netherlands Cancer Institute (NKI)
Amsterdam, Netherlands

MSK Faculty 

Gary Deng, MD, PhD
Attending, Medical Director
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Andrew Harris, MD
Associate Attending
Memorial Sloan Kettering Cancer Center

Or Kalchiem-Dekel, MD
Assistant Attending, Instructor of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Adam J. Schoenfeld, MD
Assistant Attending, Assistant Professor of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Zainab Shahid, MBBS
Associate Attending
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Valeria Silva Merea, MD
Laryngologist
Director, Speech and Hearing Center
Assistant Attending Surgeon
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Stacy Stabler, MD, PhD
Associate Attending, Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Elizabeth Yogiaveetil, MD
Assistant Attending,  Assistant Professor of Clinical Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College

Relevant Financial Relationships 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.